Delivery Order SPE2DB20D2104-SPE2DB23FU54P
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $39,357.76 firm fixed price delivery order is for the pharmaceutical product Lynparza 100 mg tablets. The contract has an ultimate completion date of June 12, 2024. Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $42,270.40 delivery order is for the supply of Lynparza 150 mg tablets and is under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 with the DLA that runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,543.70 firm fixed-price delivery order is for the supply of LYNPARZA 100 MG TABLET UU 60S, a pharmaceutical product, with a performance period through July 24, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award is a Firm Fixed Price Delivery Order for the pharmaceutical product LYNPARZA 100 MG TABLET UU 120S, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The total ceiling value of the contract is $10,519.62 with an ultimate completion date of July 3, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,414.34 firm-fixed-price delivery order is for the supply of LYNPARZA 100 MG TABLET with a completion date of November 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $9,804.78 firm fixed-price delivery order is for the supply of 4565265233 ! LYNPARZA 100 MG TABLET UU 60S, a pharmaceutical product. The contract has an ultimate completion date of August 16, 2024. AmerisourceBergen, a large pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
- This federal contract award, worth $4,887.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lynparza 150 mg tablets, a pharmaceutical product, to support DLA Troop Support Medical and other federal healthcare programs. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- This federal contract award, valued at $4,902.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to supply LYNPARZA 100 MG TABLET in 60-count units. No set-aside designation was used for this contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB20D1100|SPE2DB24FA7R2) to AmerisourceBergen Drug Corp, a subsidiary of the for-profit organization AmerisourceBergen Corporation, to provide a pharmaceutical product, LYNPARZA 150 MG TABLET UU 60S. The delivery order has a ceiling value of $4,887.36 and an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which was issued under a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on December 30, 2025, for the supply of Lynparza 100 mg tablets in quantities of 60 units. This is a firm fixed-price, non-set-aside contract with a ceiling value of $11,111.42 and an ultimate completion date of January 22, 2026. The contract will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU54PDelivery Order
This federal contract award is for the delivery of pharmaceutical products, specifically the medication Lynparza 150 mg tablet, to the Defense Logistics Agency (DLA). The $29,267.01 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 15, 2023, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation for the provision of a comprehensive range of pharmaceutical products and medical supplies. These IDCs, valued at up to $999,999,999.00 and $750,000.00 respectively, serve as critical contracting vehicles for the federal government to efficiently procure essential healthcare commodities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.3k | 7/25/23 |